$35.00
0.29 (+0.84%)
Questcor Pharmaceuticals (NASDAQ:QCOR)
CAPS Rating:
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.
A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system.